Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K6ZH
|
||||
| Former ID |
DIB006184
|
||||
| Drug Name |
PSI-661
|
||||
| Synonyms |
PSI-353661
|
||||
| Indication | HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] | Terminated | [1] | ||
| Company |
Pharmasset Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
c1(ccccc1)O[P@@](=O)(OC[C@H]1O[C@H]([C@@]([C@@H]1O)(F)C<br />)n1c2nc(nc(c2nc1)OC)N)N[C@H](C(=O)OC(C)C)C
|
||||
| Target and Pathway | |||||
| Target(s) | Hepatitis C virus NS5B polymerase | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027653) | ||||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.